India, August 09th, 2024: Eight Roads Ventures, the global investment firm backed by Fidelity, has announced the third edition of Scale-Up Health’s annual healthcare conference, on September 4, 2024 in Mumbai with McKinsey & Company as knowledge partners. Scale-Up Health, India’s first platform for healthcare and life sciences entrepreneurs and leaders, brings together the Indian entrepreneurial ecosystem to drive collaboration, build stronger networks and champion innovation.
The theme for the annual conference this year is “IndiaNXT: Disruptive Trends for 2025 & Beyond” and will focus on the global seismic shifts that have the potential to disrupt the healthcare and life sciences industry in India. The event will spotlight conversations on how these trends alongside innovation and disruptive technologies are redefining global healthcare delivery, accessibility and outcomes. The conference will host senior leaders and experts from the industry such as
Dr. Satyanarayana Chava, Founder & CEO (Laurus Labs), Vikrant Shrotriya, Managing Director & Corporate Vice President (Novo Nordisk India); Dr Shashank Joshi, Endocrinologist & President (Indian Academy of Diabetes), Dr. Vashishth Maniar, Oncologist & Co-founder, MOC Cancer Care & Research Centre, Ganesh Sabat, CEO (Sahajanand Medical Technologies), Madan Somasundaram, Co-founder & CEO, (Sugarfit); Harriet Keane PhD, Partner & Co-lead (McKinsey Cancer Center), Dr. Sridhar Peddireddy, Managing Director (Renova Hospitals), Carl Byers, Partner (F-Prime Capital), Himanshu Gadgil PhD, CEO (Enzene Biosciences) and Dr. Arpi Mehta, Co-founder & CEO (makeO).
Reflecting on the event, Dr. Prem Pavoor, Senior Partner, Head of India & India Healthcare Investments at Eight Roads Ventures, said, “The healthcare industry in India is set for a decade of disruption, innovation and growth. The country has the opportunity to capitalise on some mega trends that are driving the industry globally right now, e.g., the new class of anti-obesity drugs, impending Biosecure legislation. Scale-Up Health 2024 will spark discussions amongst global and Indian healthcare founders and leaders about such trends that have the potential to disrupt the industry in 2025 and beyond.” he added, “We launched Scale-Up Health with the aim to bring together the Indian healthcare entrepreneurial ecosystem, and our hope is that in time this platform will grow to be the largest in India as this community continues to create world-class businesses for India and the world.”
Scale-Up Health 2024 brings a unique agenda and set of conversations that are focused on the industry’s most disruptive trends. The event will see industry leaders, founders and medical experts delve into four key areas –
● The evolving treatment paradigm in oncology care
● The breakout success of GLP-1 drugs in the U.S and other parts of the world that has created a $100bn global surge of these anti-obesity drugs; we’ll see panellists weigh in on whether they see India being swept up in the wave from a demand perspective and, if India can benefit from the opportunity
● Promises and challenges of the rising medtech industry
● The potential impact of global geopolitics and impending regulations on the Indian CDMO industry. Exclusively for the event, McKinsey & Company will reveal the results of its Global and India CDMO Survey
Eight Roads Ventures has hosted two previous editions of the Scale-Up Health annual conference with McKinsey & Company as knowledge partners in 2022 (‘The New Frontier: Version 2.0 for India Life Sciences & Healthcare’) and 2023 (‘Bridging the Gap: Building Healthcare for India & the World). Alongside the annual conference, the firm also hosts smaller networking and thought leadership events throughout the year in its efforts to bring the community together.